Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 13, 2020

Total Value ($000): $205,283 (100.0% shares, 0.0% debt)

Holdings (12)

KROS Keros Therapeutics, Inc. 26.1%

Value ($000) $53,567 Shares 1,428,071 Est. Cost $30.81 Unrealized 0.0%

CYTK Cytokinetics Incorporated 18.5%

Value ($000) $37,884 Shares 1,607,292 Est. Cost $8.13 Unrealized +130.7%

KURA Kura Oncology, Inc. 10.4%

Value ($000) $21,320 Shares 1,307,982 Est. Cost $14.39 Unrealized +0.3%

FULC Fulcrum Therapeutics, Inc. 10.1%

Value ($000) $20,740 Shares 1,133,948 Est. Cost $11.62 Unrealized +35.5%

PCVX Vaxcyte, Inc. 9.6%

Value ($000) $19,624 Shares 620,821 Est. Cost $32.16 Unrealized 0.0%

— Generation Bio Co. 8.8%

Value ($000) $18,017 Shares 857,942 Est. Cost $21.00 Unrealized —

— Myokardia, Inc. 6.0%

Value ($000) $12,222 Shares 126,492 Est. Cost $47.61 Unrealized —

— Cymabay Therapeutics, Inc. 4.8%

Value ($000) $9,925 Shares 2,843,893 Est. Cost $3.49 Unrealized —

VYGR Voyager Therapeutics, Inc. 3.2%

Value ($000) $6,521 Shares 516,751 Est. Cost $21.95 Unrealized —

ORIC Oric Pharmaceuticals, Inc. 2.1%

Value ($000) $4,216 Shares 125,000 Est. Cost $31.92 Unrealized 0.0%

— Dicerna Pharmaceuticals, Inc. 0.3%

Value ($000) $635 Shares 25,000 Est. Cost $25.40 Unrealized —

— Retrophin, Inc. 0.3%

Value ($000) $612 Shares 30,000 Est. Cost $20.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
KROS	Keros Therapeutics, Inc.	1,428,071	$53,567	26.1%	$30.81	0.0%	COM	492327101
CYTK	Cytokinetics Incorporated	1,607,292	$37,884	18.5%	$8.13	+130.7%	COM	23282W605
KURA	Kura Oncology, Inc.	1,307,982	$21,320	10.4%	$14.39	+0.3%	COM	50127T109
FULC	Fulcrum Therapeutics, Inc.	1,133,948	$20,740	10.1%	$11.62	+35.5%	COM	359616109
PCVX	Vaxcyte, Inc.	620,821	$19,624	9.6%	$32.16	0.0%	COM	92243G108
—	Generation Bio Co.	857,942	$18,017	8.8%	$21.00	—	COM	37148K100
—	Myokardia, Inc.	126,492	$12,222	6.0%	$47.61	—	COM	62857M105
—	Cymabay Therapeutics, Inc.	2,843,893	$9,925	4.8%	$3.49	—	COM	23257D103
VYGR	Voyager Therapeutics, Inc.	516,751	$6,521	3.2%	$21.95	—	COM	92915B106
ORIC	Oric Pharmaceuticals, Inc.	125,000	$4,216	2.1%	$31.92	0.0%	COM	68622P109
—	Dicerna Pharmaceuticals, Inc.	25,000	$635	0.3%	$25.40	—	COM	253031108
—	Retrophin, Inc.	30,000	$612	0.3%	$20.40	—	COM	761299106